New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
09:12 EDTAFDA approves two Dako assays
Dako, an Agilent Technologies company, announced it has received approval from the FDA for the addition of Kadcyla in the labeling of two Dako companion diagnostic assays. Kadcyla is Genentech's new medicine for patients with HER2-positive metastatic breast cancer who have received prior treatment with Genentech's cancer medicine Herceptin and a taxane chemotherapy. The two assays are Dako's HercepTest and HER2 IQFISH pharmDx.
News For A From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2015
16:00 EDTAOptions Update; November 24, 2015
iPath S&P 500 VIX Short-Term Futures up 13c to 19.04, Option volume leaders: AAPL FB NFLX BAC PFE AMZN CHK TWTR GE SUNE DE AGN AAL MSFT INTC X BABA A
15:38 EDTAOptions with increasing volume: SUNE HPQ TSM PMCS TSO EPI A DE CREE
November 19, 2015
16:10 EDTAAgilent increases cash dividend to 11.5c per share
Subscribe for More Information
November 17, 2015
08:43 EDTAAgilent pullback after earnings a buying opportunity, says Cowen
Cowen said any pullback in Agilent after its Q4 earnings report would be a buying opportunity. Even though guidance was lower than expected, the firm still thinks 2017 targets are achievable. Cowen maintained its Market Perform rating and $39 price target on Agilent shares.
November 16, 2015
18:26 EDTAOn The Fly: After Hours Movers
UP AFTER EARNINGS: Nuance (NUAN), up 9.5%. ALSO HIGHER: Ocera Therapeutics (OCRX), up 26.6% after announcing Phase 1 study results for the company's oral formulation of OCR-002. DOWN AFTER EARNINGS: Urban Outfitters (URBN), down 11.5%... Agilent (A), down 1.3%. ALSO LOWER: Wayfair (W), down 2% after Bloomberg reported that Whitney Tilson said that Wayfair is currently his largest short.
16:10 EDTAAgilent reports Q4 LSAG revenue down 4% to $515M
Subscribe for More Information
16:09 EDTAAgilent sees FY16 adjusted EPS $1.85-$1.91, consensus $1.97
Sees FY16 revenue $4.15B-$4.17B, consensus $4.21B.
16:08 EDTAAgilent sees Q1 adjusted EPS 42c-44c, consensus 47c
Subscribe for More Information
16:07 EDTAAgilent reports Q4 adjusted EPS 50c, consensus 47c
Subscribe for More Information
15:02 EDTANotable companies reporting after market close
Subscribe for More Information
November 11, 2015
08:44 EDTAAgilent November volatility elevated into Q3 and outlook
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use